Cargando…

PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling

SIMPLE SUMMARY: Combined menopausal hormone therapy is associated with increased breast cancer risk in postmenopausal women. In our previous studies, progesterone receptor membrane component 1 (PGRMC1) was shown to play a role in progestins’ elicitation of enhanced proliferation of breast cancer cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Yingxue, Ludescher, Marina, Poschmann, Gereon, Stühler, Kai, Wyrich, Martine, Oles, Julia, Franken, André, Rivandi, Mahdi, Abramova, Anna, Reinhardt, Florian, Ruckhäberle, Eugen, Niederacher, Dieter, Fehm, Tanja, Cahill, Michael A., Stamm, Nadia, Neubauer, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615993/ https://www.ncbi.nlm.nih.gov/pubmed/34830790 http://dx.doi.org/10.3390/cancers13225635

Ejemplares similares

Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells
por: Willibald, Marina, et al.
Publicado: (2017)

PGRMC Proteins Are Coming of Age: A Special Issue on the Role of PGRMC1 and PGRMC2 in Metabolism and Cancer Biology
por: Cahill, Michael A., et al.
Publicado: (2021)

DanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts
por: Reinhardt, Florian, et al.
Publicado: (2023)

Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression
por: Asperger, Hannah, et al.
Publicado: (2020)

Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1
por: Neubauer, Hans, et al.
Publicado: (2008)

Correction: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1
por: Neubauer, Hans, et al.
Publicado: (2009)

PGRMC1 and PGRMC2 in uterine physiology and disease
por: Pru, James K., et al.
Publicado: (2013)

Correction to: Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression
por: Asperger, Hannah, et al.
Publicado: (2021)

PGRMC1 effects on metabolism, genomic mutation and CpG methylation imply crucial roles in animal biology and disease
por: Thejer, Bashar M., et al.
Publicado: (2020)

Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance
por: Reinhardt, Florian, et al.
Publicado: (2019)

PGRMC1 phosphorylation affects cell shape, motility, glycolysis, mitochondrial form and function, and tumor growth
por: Thejer, Bashar M., et al.
Publicado: (2020)

Progesterone Receptor Membrane Component (PGRMC)1 and PGRMC2 and Their Roles in Ovarian and Endometrial Cancer
por: Peluso, John J., et al.
Publicado: (2021)

PGRMC1 regulation by phosphorylation: potential new insights in controlling biological activity!
por: Cahill, Michael A., et al.
Publicado: (2016)

Zebrafish heart development is regulated via glutaredoxin 2 dependent migration and survival of neural crest cells
por: Berndt, Carsten, et al.
Publicado: (2014)

A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM(high) and EpCAM(low/negative) CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer
por: Lampignano, Rita, et al.
Publicado: (2017)

Epitope mapping of anti-PGRMC1 antibodies reveals the non-conventional membrane topology of PGRMC1 on the cell surface
por: Kim, Ji Yea, et al.
Publicado: (2019)

Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients
por: Krawczyk, Natalia, et al.
Publicado: (2019)

Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer – A Feasibility Study
por: Jaeger, Bernadette Anna Sophia, et al.
Publicado: (2023)

Multiparametric Circulating Tumor Cell Analysis to Select Targeted Therapies for Breast Cancer Patients
por: Franken, André, et al.
Publicado: (2021)

The GABARAP Co-Secretome Identified by APEX2-GABARAP Proximity Labelling of Extracellular Vesicles
por: Sanwald, Julia L., et al.
Publicado: (2020)

OutCyte: a novel tool for predicting unconventional protein secretion
por: Zhao, Linlin, et al.
Publicado: (2019)

Secretomics—A Key to a Comprehensive Picture of Unconventional Protein Secretion
por: Poschmann, Gereon, et al.
Publicado: (2022)

Pgrmc1 Knockout Impairs Oocyte Maturation in Zebrafish
por: Wu, Xin-Jun, et al.
Publicado: (2018)

Prohibitin-1 Transgenic Mice Revealed an Important Role of Prohibitin in Testicular Steroidogenesis
por: Bassi, Geetika, et al.
Publicado: (2021)

The effects of a music intervention during port catheter placement on anxiety and stress
por: Schaal, Nora K., et al.
Publicado: (2021)

Is the (Neo)adjuvant Therapy of Patients with Primary HER2-positive Breast Cancer Cost-Covering?: Process Cost Analysis of Neoadjuvant and Post-Neoadjuvant Systemic Therapy of Patients with Primary HER2-positive Breast Cancer
por: Krawczyk, Natalia, et al.
Publicado: (2022)

PGRMC2 is an Intracellular Heme Chaperone Critical for Adipocyte Function
por: Galmozzi, Andrea, et al.
Publicado: (2019)

Insights on the Role of PGRMC1 in Mitotic and Meiotic Cell Division
por: Lodde, Valentina, et al.
Publicado: (2022)

Prohibitins in neurodegeneration and mitochondrial homeostasis
por: Fernandez-Abascal, Jesus, et al.
Publicado: (2022)

Expression of Progesterone Receptor Membrane Component 1 (PGRMC1), Progestin and AdipoQ Receptor 7 (PAQPR7), and Plasminogen Activator Inhibitor 1 RNA-Binding Protein (PAIRBP1) in Glioma Spheroids In Vitro
por: Hlavaty, Juraj, et al.
Publicado: (2016)

Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value
por: Franken, André, et al.
Publicado: (2023)

PGRMC1 acts as a size-selective cargo receptor to drive ER-phagic clearance of mutant prohormones
por: Chen, Yu-Jie, et al.
Publicado: (2021)

Induction of Paclitaxel Resistance by ERα Mediated Prohibitin Mitochondrial-Nuclear Shuttling
por: Dong, Pei, et al.
Publicado: (2013)

A Proteome Approach Reveals Differences between Fertile Women and Patients with Repeated Implantation Failure on Endometrial Level—Does hCG Render the Endometrium of RIF Patients?
por: Bielfeld, Alexandra P., et al.
Publicado: (2019)

The Puzzle of Metabolite Exchange and Identification of Putative Octotrico Peptide Repeat Expression Regulators in the Nascent Photosynthetic Organelles of Paulinella chromatophora
por: Oberleitner, Linda, et al.
Publicado: (2020)

PGRMC1: a new biomarker for the estrogen receptor in breast cancer
por: Craven, Rolf J
Publicado: (2008)

Comprehensive Analysis of the Implication of PGRMC1 in Triple-Negative Breast Cancer
por: Xu, Xin, et al.
Publicado: (2021)

The PGRMC1 Antagonist AG-205 Inhibits Synthesis of Galactosylceramide and Sulfatide
por: Wang-Eckhardt, Lihua, et al.
Publicado: (2021)

Opposing function of mitochondrial prohibitin in aging
por: Artal-Sanz, Marta, et al.
Publicado: (2010)

The Prohibitins: emerging roles in diverse functions
por: Mishra, Suresh, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_6cn5p1qo89srlpjni9f4st6ufu